PAMFYBRO
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Dec 2024)
What this means for you
This application is over — abandoned 16 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97109140
- Mark type
- Stylized text
- Filed
- 04 Nov 2021
- Published for opposition
- 20 Sept 2022
- Abandoned
- 16 Dec 2024
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis
Owner
- FibroGen, Inc., San Francisco, CA, US
- FibroGen, Inc., San Francisco, CA, US
Prosecution history
- 16 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2024 — SOU EXTENSION 3 GRANTED
- 03 Apr 2024 — SOU EXTENSION 3 FILED
- 03 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Oct 2023 — SOU EXTENSION 2 GRANTED
- 04 Oct 2023 — SOU EXTENSION 2 FILED
- 04 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2023 — SOU EXTENSION 1 GRANTED